| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $152,875 | 3 | 50 |
Sells | $144,469 | 3 | 50 |
| HRT FINANCIAL LP | 10 percent owner | 3 | $152,875 | 3 | $144,469 | $8,406 |
Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication. This prescription drug combines finasteride and tadalafil to manage benign prostatic hyperplasia (BPH). In its development pipeline, Onconetix is advancing a Streptococcus pneumoniae vaccine candidate, designed to prevent infectious middle ear infections in children …
Over the last 12 months, insiders at Onconetix, Inc. have bought $152,875 and sold $144,469 worth of Onconetix, Inc. stock.
On average, over the past 5 years, insiders at Onconetix, Inc. have bought $152,875 and sold $144,469 worth of stock each year.
Highest buying activity among insiders over the last 12 months: HRT FINANCIAL LP (10 percent owner) — $152,875.
The last purchase of 34,636 shares for transaction amount of $25,284 was made by HRT FINANCIAL LP (10 percent owner) on 2026‑04‑17.
| 2026-04-21 | Sale | HRT FINANCIAL LP | 10 percent owner | 49,710 1.4791% | $0.69 | $34,300 | -86.91% | |
| 2026-04-20 | Sale | HRT FINANCIAL LP | 10 percent owner | 94,462 2.8247% | $0.75 | $70,847 | -87.85% | |
| 2026-04-17 | HRT FINANCIAL LP | 10 percent owner | 34,636 0.9972% | $0.73 | $25,284 | -87.96% | ||
| 2026-04-16 | Sale | HRT FINANCIAL LP | 10 percent owner | 53,867 1.5101% | $0.73 | $39,323 | -88.27% | |
| 2026-04-15 | HRT FINANCIAL LP | 10 percent owner | 92,554 2.6959% | $0.76 | $70,341 | -88.28% | ||
| 2026-04-14 | HRT FINANCIAL LP | 10 percent owner | 74,350 1.3696% | $0.77 | $57,250 | -90.20% |
| Increased Positions | 3 | +33.33% | 14,775 | +15.13% |
| Decreased Positions | 3 | -33.33% | 51,371 | -52.6% |
| New Positions | <1 | New | 10,827 | New |
| Sold Out Positions | 2 | Sold Out | 28,633 | Sold Out |
| Total Postitions | 9 | 0% | 61,061 | -37.47% |